Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brandicourt’s Message To Sanofi Investors: Grow, Build, Explore Options

This article was originally published in The Pink Sheet Daily

Executive Summary

CEO Olivier Brandicourt's multi-pronged strategy involves defending in core areas like diabetes, vaccines and rare diseases, building in consumer healthcare, oncology and multiple sclerosis and reviewing strategic alternatives in other areas, including animal health.

Advertisement

Related Content

Sanofi Board Forces CEO Chris Viehbacher to Resign Amid Lantus Woes

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS077976

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel